Prof. Randall E. Harris

The Ohio State University Medical Center, USA

Email: Harris.44@osu.edu

Qualifications

1983  M.D., University of Nebraska

1974  Ph.D., North Carolina State University

1971  M.Sc., University of Nebraska

Publications (selected)

1. Epidemiology of Chronic Disease: Global Perspectives. Randall E. Harris ,Jones & Bartlett Learning , Sudbury, MA (Publication Date, 4/25/2012), ISBN-13: 9781449653286, ISBN-10:1449653286
2. Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy, Randall E. Harris (Editor), Series on Subcellular Biochemistry, Volume 42, Springer, The Netherlands, April, 2007, pp 339. ISBN-10 1-4020-5687-7
3. COX-2 Blockade in Cancer Prevention and Therapy. Randall E. Harris (Editor),Beverly Teicher’s Series on Cancer Drug Discovery and Development, Humana Press, Inc., Totowa, NJ, Oct 2002, pp 371. ISBN: 1-58829-010-7.
4. Harris RE, Beebe-Donk JD, Alshafie GA.  Cancer chemoprevention by selective cyclooxygenase-2 (COX-2) blockade:  results of case control studies.  Subcellular Biochemistry 42: 83-126, 2007.
5. Harris RE.  COX-2 and the inflammogenesis of cancer. Subcellular Biochemistry 42: 193-212, 2007.
6. Harris RE. Review: Antiangiogenesis: New Frontiers in Therapeutic Development - IBC's Fourth Annual Symposium - 16-17 October 2006, Boston, MA.  IDrugs 9(12): 834-836, 2006.
7. Harris RE, Beebe-Donk J, Alshafie Galal. Reduction in the Risk of Human Breast Cancer by Selective Cyclooxygenase-2 (COX-2) Inhibitors: Final Results of a Case Control Study.  International Journal of Cancer Prevention 3 (1/2), 1-7, 2007.
8. Clark BR, Ferketich AK, Fisher JL, Ruymann FB, Harris RE, Wilkins JR 3rd.   Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio.   Pediatr Blood Cancer 49 (6): 797-802, 2007.
9. Harris RE, Beebe-Donk J, Alshafie GA.  Reduced risk of human lung cancer by selective cyclooxygenase-2 (COX-2) blockade:  results of a case control study.  International Journal of Biological Sciences 3(5): 328-334, 2007.
10. Harris RE, Beebe-Donk J, Alshafie GA.  Similar reductions in the risk of human colon cancer by selective and non-selective cyclooxygenase-2 (COX-2) inhibitors.  BMC Cancer 8 (237): Aug 14, 2008.
11. Harris RE.  Cyclooxygenase-2 (COX-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.  Inflammo-pharmacology 17, 1-13, 2009.
12. Landers TF, Harris RE, Wittum TE, Stevenson KB. Colonization with Staphylococcus aureus and methicillin-resistant S. aureus among a sample of homeless individuals, Ohio.  Infect Control Hosp. Epidemiol. Aug;30(8): 2009. 801-803.
13. Harris RE.  Epidemiology of breast cancer. Review.  Encyclopedia of Cancer; Manfred Schwab, Germany (Ed); Springer, 2010.
14. Harris RE.  Epidemiology of prostate cancer. Review.  Encyclopedia of Cancer;  Manfred  Schwab, Germany (Ed); Springer, 2010.
15. Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yankeelov T; National Comprehensive Cancer Network.  Breast cancer screening and diagnosis.  2009, V.1.2010, J Natl Compr Canc Netw. 2009 Nov;7(10):1060-1096.
16. Epidemiology of Chronic Disease:Global Perspectives, By Randall E. Harris, MD, PhD